Publications by authors named "Karl Patterson"

Claim this Profile
E
Evaluating the broad societal value of pembrolizumab in women's cancer in Brazil.
Nishini Wijenayake, Daniel Ladino, Karl Patterson, Mariana Rosim, Mónica Rojas Rojas

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes.
Rose J Hart, Fareen Hassan, Sarah Alulis, Karl W Patterson, Jennifer Norma Barthelmes

Adv Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted literature review exploring the predictive value of estimated glomerular filtration rate and left ventricular mass index as indicators of clinical events in Fabry disease.
Ben Haycroft, Abigail Stevenson, Richard Stork, Stuart Gaffney, Philip Morgan, Karl Patterson

Orphanet J Rare Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States.
Oliver Hale, Karl Patterson, Yizhen Lai, Yang Meng, Haojie Li

Clin Genitourin Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Stick or Twist?" Negotiating Price and Data in an Era of Conditional Approval.
Daniel Gladwell, Ash Bullement, Warren Cowell, Karl Patterson, Mark Strong

Value Health· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy.
Karl Patterson, Vimalanand Prabhu, Ruifeng Xu, Haojie Li, Yang Meng

Eur Urol Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.
Karl Patterson, Lovleen Arya, Sarah Bottomley, Susan Morgan, Angela Cox

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human CDK18 promotes replication stress signaling and genome stability.
Giancarlo Barone, Christopher J Staples, Anil Ganesh, Karl W Patterson, Dominic P Bryne

Nucleic Acids Res· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
Arvind Arora, Tarek M A Abdel-Fatah, Devika Agarwal, Rachel Doherty, Deborah L Croteau, Karl Patterson

Carcinogenesis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis